Advantest
6857
Shin-Etsu Chemical
4063
FUJI Media Holdings
4676
4
Fujikura
5803
5
Metaplanet
3350
JP Stock MarketDetailed Quotes
4886 ASKA Pharmaceutical Holdings
- 1963
- 00.00%
20min DelayMarket to Open Jan 29 15:30 JST
60.00BMarket Cap7.37P/E (Static)
0High0Low0Volume0Open1963Pre Close0.00Turnover272052wk High0.00%Turnover Ratio30.56MShares184052wk Low210.94EPS TTM34.56BFloat Cap2720Historical High7.37P/E (Static)17.61MShs Float919Historical Low266.51EPS LYR0.00%Amplitude45.00Dividend TTM0.87P/B100Lot Size2.29%Div YieldTTM
ASKA Pharmaceutical Holdings Key Stats
EPS
According to the latest financial report of ASKA Pharmaceutical Holdings, the latest earnings per share (TTM) for the company is 44.95. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about ASKA Pharmaceutical Holdings's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ASKA Pharmaceutical Holdings shows that the company's current ratio is 2.82, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ASKA Pharmaceutical Holdings, the quick ratio is 1.57, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of ASKA Pharmaceutical Holdings? The latest ROE figure is 1.78%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ASKA Pharmaceutical Holdings, the total asset return on investment (ROA) is 1.17%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check ASKA Pharmaceutical Holdings's latest financial report to see how their gross margin is doing - currently at 49.97%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ASKA Pharmaceutical Holdings, the net profit margin is 7.78%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...